Special Issue "Honey Bee Products as an Alternative or Complement to Classical Antibiotics"
A special issue of Antibiotics (ISSN 2079-6382).
Deadline for manuscript submissions: closed (30 September 2020) | Viewed by 66427
Interests: bacteria and yeast drug resistance; staphylococcus aureus; Candida spp.; bee products; essential oils; peptidoglycan hydrolases
Special Issues, Collections and Topics in MDPI journals
Special Issue in Antibiotics: Uropathogens - Antibiotic Resistance and Alternative Therapies
Special Issue in Antibiotics: Uropathogens—Antibiotic Resistance and Alternative Therapies, 2nd Edition
Special Issue in Antibiotics: Positive and Negative Interactions between Classical Antibacterial, Antibiotics, Antifungals and Natural Products
For some years now, we have been witnessing with concern the arrival of the post-antibiotic era. The resistance of pathogenic bacteria and fungi to well-known antibiotics and synthetic chemotherapeutics is becoming a major global health-care challenge. Therefore, there is a great need to find novel, non-antibiotic chemotherapeutics with marked antibacterial/antifungal activity.
Bee products, including honey, propolis, royal jelly, pollen and fermented pollen, and bee bread, constitute a promising but still underestimated group of potential antimicrobial chemotherapeutics. For centuries, bee honey and propolis comprised the most important raw materials of folk medicine. They were successfully used in the treatment of a wide array of human diseases, including infections (mainly within the upper respiratory tract and chronic wounds). In contrast to many other popular traditional medicines, the achievements of modern medicine confirm the diverse therapeutic potential of bee products, which is a consequence of their chemical composition. The outcomes of several studies also confirmed synergistic interaction of propolis with classical antibiotics and synthetic chemotherapeutics. Therefore, the main subject of this Special Issue is all aspects of the possible application of bee products (and the chemical ingredients in these products) for the treatment of bacterial or fungal infections.
Dr. Piotr Szweda
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- bacteria and fungi drug resistance
- royal jelly
- bee bread
- bee products